Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ACADIA Pharmaceuticals Inc.”

77 pharma patents match "ACADIA Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 77
Index total 30,257
Page 2 / 4

Quick answer

This filtered view shows 77 pharmaceutical patents matching "ACADIA Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

77 results for “ACADIA Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 9050343

    Combination of pimavanserin and risperidone for the treatment of psychosis

    ACADIA Pharmaceuticals Inc. · Granted Jun 9, 2015 · Expires Jun 4, 2035

    granted
  2. US 8921393

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  3. US 8822548

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  4. US 8680115

    Tetrahydroquinoline analogues as muscarinic agonists

    ACADIA Pharmaceuticals Inc. · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted
  5. US 8618130

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted
  6. US 8470872

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted
  7. US 8377959

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 19, 2013 · Expires Feb 14, 2033

    granted
  8. US 8236960

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  9. US 8227487

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted
  10. US 8101651

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  11. US 8008323

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Aug 30, 2011 · Expires Aug 25, 2031

    granted
  12. US 7994193

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted
  13. US 7923564

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted
  14. US 7875632

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted
  15. US 7868176

    Salts of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-y1)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and their preparation

    ACADIA Pharmaceuticals Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  16. US 7863296

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  17. US 7825265

    Compounds with activity at estrogen receptors

    ACADIA Pharmaceuticals Inc. · Granted Nov 2, 2010 · Expires Oct 28, 2030

    granted
  18. US 7820695

    Selective serotonin receptor inverse agonists as therapeutics for disease

    ACADIA Pharmaceuticals Inc. · Granted Oct 26, 2010 · Expires Oct 21, 2030

    granted
  19. US 7790899

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted
  20. US 7732615

    N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted
  21. US 7732462

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted
  22. US 7727999

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Jun 1, 2010 · Expires May 27, 2030

    granted
  23. US 7713995

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted May 11, 2010 · Expires May 6, 2030

    granted
  24. US 7659285

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted